From the *Global Health and Population Business Unit, FHI 360, Abidjan, Côte d’Ivoire
†Global Health and Population Business Unit, FHI 360, Washington, DC
‡US Centers for Disease Control and Prevention, Division of Global HIV and TB, Atlanta, Georgia
§Food Security and Agriculture Division, RTI, Durham, North Carolina
¶US President's Malaria Initiative (PMI), US Centers for Disease Control and Prevention, USAID, Liberia
‖Programme MTaPS, MSH, Abidjan, Cote d’Ivoire
**Division of Global HIV and TB, US Centers for Disease Control and Prevention, Abidjan, Côte d’Ivoire
††Service Recherche, Programme National de Lutte contre le Sida (PNLS), Abidjan, Côte d’Ivoire
‡‡Department of Global Health, ITECH UW, Abidjan, Côte d’Ivoire.
Accepted for publication December 12, 2022
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the funding agencies.
This publication has been supported by the President’s Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of 1U2GGH001162.
The authors have no conflicts of interest to disclose.
The idea for the study started by M.O.D. F.T. and G.E. outlined the article. F.T., G.E., D.C. and C.B. wrote the first draft, which was reviewed by D.C., K.P., E.R., M.O.D., A.E., H.V. and F.K. The final draft was reviewed and approved by all authors.
Claire Brennan, MPH, was formerly with FHI 360, Durham, North Carolina. Ange Fulgence Ouffoue, MD, MPH, and Christian Gnongoue, MSc, MPH, were formerly with FHI 360, Abidjan, Côte d’Ivoire.
Address for correspondence: Fatoumata Touré, MD, PhD, Global Health and Population Business Unit, FHI 360, rue J99, J14, J8 Abidjan, Côte d’Ivoire. E-mail: [email protected].
